CLINICAL_TRIALS
trial_result
· 2013-12-10
Clinical Trial Update: Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty [Phase 3]
Summary
A completed Phase 3 safety-extension trial evaluated leuprolide acetate (Lupron Depot) for central precocious puberty, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Precocious, Leuprolide Acetate | Phase 3 | Status: COMPLETED | Results posted: 2013-12-10